Publicaciones en las que colabora con Pablo Aguiar Fernández (9)

2024

  1. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  2. Quantitative brain [18F]FDG PET beyond normal blood glucose levels

    NeuroImage, Vol. 300

2022

  1. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

2021

  1. Correction to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer? (European Radiology, (2021), 31, 6, (4156-4165), 10.1007/s00330-020-07507-z)

    European Radiology

  2. Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection

    Pharmaceutics, Vol. 13, Núm. 3

  3. Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats

    Molecular Imaging and Biology, Vol. 23, Núm. 3, pp. 350-360

  4. Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?

    European Radiology, Vol. 31, Núm. 6, pp. 4156-4165

2020

  1. White matter hyperintensities are associated with subthreshold amyloid accumulation

    NeuroImage, Vol. 218

2019

  1. Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model

    International Journal of Pharmaceutics, Vol. 572